Diagnostic system for selecting nutrition and pharmacological products for animals
First Claim
1. A method of analyzing the diagnostic genetic profile of a non-human animal comprising:
- (a) providing a genotypic database for the species of the non-human animal subject or a selected group of the non-human species;
(b) obtaining animal phenotypic data;
(c) correlating the database of (a) with the data of (b) to determine a relationship between the database of (a) and the data of (b); and
(d) determining a diagnostic genetic profile of the animal or selected group of animals based on the correlating step (c), and selecting the biologically active nutrient from an obtained molecular dietary signature, the molecular dietary signature being a variation of expression of a set of genes which may differ for the genotype of each animal or selected group of animals.
1 Assignment
0 Petitions
Accused Products
Abstract
An analysis of the profile of a non-human animal comprises: a) providing a genotypic database to the species of the non-human animal subject or a selected group of the species; b) obtaining animal data; c) correlating the database of a) with the data of b) to determine a relationship between the database of a) and the data of b); c) determining the profile of the animal based on the correlating step; and d) determining a genetic profile based on the molecular dietary signature, the molecular dietary signature being a variation of expression of a set of genes which may differ for the genotype of each animal or a group of animals Nutrition and pharmalogical assessments are made. Reporting the determination is by the Intemet, and payment for the report is obtained through the Internet.
-
Citations
24 Claims
-
1. A method of analyzing the diagnostic genetic profile of a non-human animal comprising:
-
(a) providing a genotypic database for the species of the non-human animal subject or a selected group of the non-human species; (b) obtaining animal phenotypic data; (c) correlating the database of (a) with the data of (b) to determine a relationship between the database of (a) and the data of (b); and (d) determining a diagnostic genetic profile of the animal or selected group of animals based on the correlating step (c), and selecting the biologically active nutrient from an obtained molecular dietary signature, the molecular dietary signature being a variation of expression of a set of genes which may differ for the genotype of each animal or selected group of animals. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13)
-
-
14. A method of diagnosing a healthy, unhealthy or physiological disorder, or a predisposition to disease or physiological disorder for an individual animal, comprising:
-
(a) using a “
reference”
dataset containing functional genomic profiles of biological samples of the genotypes of different animals of the species, the different animals being healthy animals;(b) selecting a “
target group”
dataset containing the functional genomic profile of biological samples of the genotypes of different animals, the different animals being unhealthy animals;(c) using a “
biologically active nutrient”
dataset comprising different effects of biologically active nutritional components on functional genomic profiles of the different animals of different genotypes from those of the target group (b), the different genotypes being differently responsive to the same biologically active nutritional components;(d) having the reference group or target group include the individual animal; and (e) relating at least one of the “
reference”
or “
target group”
datasets with the “
biologically active nutrient”
dataset to identify a biologically active nutrient for the selected animal genotype to prevent, treat, control, or modulate a state of physiological homeostasis or pathophysiological condition of the individual animal in the reference group or target group. - View Dependent Claims (15)
-
-
16. A method of diagnosing a healthy, unhealthy or physiological disorder, or a predisposition to disease or physiological disorder for animals, comprising:
-
(a) using a “
reference”
dataset containing functional genomic profiles of biological samples of the genotypes of different animals of the species, the different animals being healthy animals;(b) selecting a “
target group”
dataset containing the functional genomic profile of biological samples of the genotypes of different animals, the animals being unhealthy animals;(c) using a “
biologically active nutrient”
dataset comprising different effects of biologically active nutritional components on functional genomic profiles of-the different animals of different genotypes from those of the target group (b), the different genotypes being differently responsive to the same biologically active nutritional components;(d) having the reference group or target group include the animals; and (e) relating at least one of the “
reference”
or “
target group”
datasets with the “
biologically active nutrient”
dataset to identify a biologically active nutrient for the selected animal genotypes to prevent, treat, control, or modulate a state of physiological homeostasis or pathophysiological condition of the animal in the reference group or target group., and the relating being by using an analysis of gene or protein expression or the metabolytes in the biological sample of the target group. - View Dependent Claims (17)
-
-
18. A method of identifying a pharmacological product for an individual animal having a genotype, comprising:
-
(a) using a “
reference”
dataset containing functional genomic profiles of biological samples of the genotypes of different animals of the species, the different animals being healthy animals;(b) selecting a “
target”
dataset containing the functional genomic profile of biological samples of the genotypes of different animals, the different animals being unhealthy animals;(c) using a “
pharmacological product ”
dataset comprising different effects of pharmacological product on functional genomic profiles of the different animals of different genotypes from those of the target group (b), the different genotypes being differently responsive to the same pharmacological product;(d) having the reference dataset or target dataset include an individual animal for which the biologocallly active nutrient is to be identified; and (e) relating at least one of the “
reference”
or “
target group”
datasets with the pharmacological product dataset to identify pharmacological product. is for the selected animal genotype to prevent, treat, control, or modulate a state of physiological homeostasis or pathophysiological condition of the individual animal in the reference dataset or target group. - View Dependent Claims (19, 20, 21, 22, 23)
-
-
24. A method of identifying a pharmacological product for animals, comprising:
-
(a) using a “
reference”
dataset containing functional genomic profiles of biological samples of the genotypes of different animals of the species, the different animals being healthy animals;(b) selecting a “
target group”
dataset containing the functional genomic profile of biological samples of the genotypes of different animals, the animals being unhealthy animals;(c) using a “
pharmacological product”
dataset comprising different effects of pharmacological product on functional genomic profiles of the different animals of different genotypes from those of the target group (b), the different genotypes being differently responsive to the same pharmacological product;(d) having the reference group or target group include the animals; and (e) relating at least one of the “
reference”
or “
target group”
datasets with the pharmacological product dataset to identify a biologically active nutrient for the selected animal genotypes to prevent, treat, control, or modulate a state of physiological homeostasis or pathophysiological condition of the animal in the reference dataset or target group, and the analyzing the gene or protein expression or the metabolite expression in the biological samples of the target dataset.
-
Specification